A CD8 T Cell/Indoleamine 2,3-Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
出版年份 2014 全文链接
标题
A CD8 T Cell/Indoleamine 2,3-Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
作者
关键词
-
出版物
Arthritis & Rheumatology
Volume 66, Issue 8, Pages 2234-2245
出版商
Wiley
发表日期
2014-04-23
DOI
10.1002/art.38674
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Excessive Production of IFN- in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B
- (2014) M. Harigai et al. JOURNAL OF IMMUNOLOGY
- Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome
- (2012) J. Xu et al. BLOOD
- Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
- (2012) Kentaro Akiyama et al. Cell Stem Cell
- Mesenchymal Stromal Cells: New Directions
- (2012) Armand Keating Cell Stem Cell
- Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice
- (2012) Fei Gu et al. CLINICAL IMMUNOLOGY
- Enhanced Apoptosis and Senescence of Bone-Marrow-Derived Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
- (2012) Xia Li et al. STEM CELLS AND DEVELOPMENT
- Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis
- (2011) D. Wang et al. ANNALS OF THE RHEUMATIC DISEASES
- Phenotype and function of natural killer cells in systemic lupus erythematosus: Excess interferon-γ production in patients with active disease
- (2011) Baptiste Hervier et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
- (2011) Maria T Pallotta et al. NATURE IMMUNOLOGY
- Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study
- (2010) J. Liang et al. ANNALS OF THE RHEUMATIC DISEASES
- Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
- (2010) Lingyun Sun et al. ARTHRITIS AND RHEUMATISM
- Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?
- (2010) Karen English et al. Cell Stem Cell
- Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing
- (2010) Hiroshi Yagi et al. CELL TRANSPLANTATION
- Dendritic Cells in Lupus Are Not Required for Activation of T and B Cells but Promote Their Expansion, Resulting in Tissue Damage
- (2010) Lino L. Teichmann et al. IMMUNITY
- Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease
- (2010) Xiaofeng Qian et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells
- (2010) Clemens Scheinecker et al. JOURNAL OF AUTOIMMUNITY
- Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN- Targeting Gene Therapy
- (2010) Toshiharu Hayashi JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus
- (2010) Y. Nie et al. LUPUS
- T cells as therapeutic targets in SLE
- (2010) José C. Crispín et al. Nature Reviews Rheumatology
- B cells as therapeutic targets in SLE
- (2010) Iñaki Sanz et al. Nature Reviews Rheumatology
- Activation of the interferon-γ signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells
- (2009) Thomas Karonitsch et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality
- (2009) L. K. Jasperson et al. BLOOD
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
- (2009) Xiaoyu Hu et al. IMMUNITY
- Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients
- (2009) F. Carrion et al. LUPUS
- Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans
- (2009) Lingyun Sun et al. STEM CELLS
- HLA-G is a Crucial Immunosuppressive Molecule Secreted by Adult Human Mesenchymal Stem Cells
- (2009) Zohair Selmani et al. TRANSPLANTATION
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
- (2008) Guangwen Ren et al. Cell Stem Cell
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now